<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>217</id><JournalTitle>ALLOXAN-INDUCED DIABETES IN ANIMAL MODELS OF PIOGLITAZONE'S ANTIDIABETIC EFFECT</JournalTitle><Abstract>The research involves testing the drug pioglitazone, which is used to treat type 2 diabetes and works well. Researchers used
three animal models to six mice each to study how pioglitazone affects diabetes from a pharmacological point of view. A first
model was just a group that didn't get any treatment. The other 2 models were made of alloxan, and one was given medicine
and the other was not. Animals were given Alloxan so that they would get diabetes. Alloxan is a -cytotoxin that is also known
as mesoxalylurea, mesoxalylcarbamide, 2, 4, 5, 6-tetra-oxohexahye-4-pyrimide, & pyrimidine tetrone. It's been used a lot to
give animals what is called "chemical diabetes" in real life.Compared to the vehicle, Pioglitazone lowered the blood sugar
levels of diabetic mice made by alloxan (70 mg/kg)</Abstract><Email>Ravi@gmail.com</Email><articletype>Research</articletype><volume>11</volume><issue>2</issue><year>2021</year><keyword>Alloxan, Pioglitazone, and Diabetes Treatmen</keyword><AUTHORS>Ravi P</AUTHORS><afflication>Assistant Professor, Department of Pharmacology, Bhaarath Medical College & Hospital, Selaiyur, Chennai, Tamil Nadu 600073, India</afflication></Article></Articles>